Tikvah Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$26.8M Hold
111,084
8.63% 4
2025
Q1
$27.1M Sell
111,084
-7,063
-6% -$1.72M 9.22% 3
2024
Q4
$38.8M Hold
118,147
10.57% 3
2024
Q3
$39.5M Hold
118,147
12.25% 2
2024
Q2
$32.3M Hold
118,147
10.52% 3
2024
Q1
$40.9M Hold
118,147
12.8% 2
2023
Q4
$38.1M Hold
118,147
13.09% 2
2023
Q3
$42.3M Hold
118,147
15.19% 2
2023
Q2
$44.8M Buy
118,147
+21,120
+22% +$8.01M 15.23% 2
2023
Q1
$46.5M Hold
97,027
19.1% 1
2022
Q4
$40.8M Hold
97,027
19.48% 1
2022
Q3
$40.5M Hold
97,027
18.71% 2
2022
Q2
$48M Hold
97,027
20.7% 1
2022
Q1
$54.6M Buy
+97,027
New +$54.6M 17.47% 2
2021
Q2
Sell
-126,282
Closed -$72.1M 19
2021
Q1
$72.1M Hold
126,282
20.23% 1
2020
Q4
$73.6M Hold
126,282
20.52% 1
2020
Q3
$65.1M Sell
126,282
-11,730
-8% -$6.05M 20.1% 1
2020
Q2
$62.3M Hold
138,012
19.05% 2
2020
Q1
$48.4M Sell
138,012
-11,400
-8% -$4M 19.15% 2
2019
Q4
$55.3M Hold
149,412
14.3% 1
2019
Q3
$49.7M Hold
149,412
13.86% 1
2019
Q2
$46.7M Hold
149,412
13.25% 2
2019
Q1
$45.7M Buy
149,412
+5
+0% +$1.53K 15.16% 2
2018
Q4
$34.7M Hold
149,407
12.31% 3
2018
Q3
$46.8M Hold
149,407
13.98% 3
2018
Q2
$43.1M Hold
149,407
13.53% 3
2018
Q1
$37.4M Buy
149,407
+11,400
+8% +$2.85M 11.48% 3
2017
Q4
$32.9M Hold
138,007
13.25% 2
2017
Q3
$30.7M Hold
138,007
13% 2
2017
Q2
$31.2M Hold
138,007
14.7% 2
2017
Q1
$27.5M Hold
138,007
14.43% 1
2016
Q4
$25.2M Hold
138,007
12.36% 2
2016
Q3
$22.6M Hold
138,007
11.8% 2
2016
Q2
$19.7M Hold
138,007
11.55% 3
2016
Q1
$18.9M Hold
138,007
10.49% 4
2015
Q4
$19.1M Buy
138,007
+28,900
+26% +$4.01M 10.03% 4
2015
Q3
$14.7M Hold
109,107
8.16% 4
2015
Q2
$16.4M Buy
109,107
+13,910
+15% +$2.1M 8.72% 4
2015
Q1
$12.9M Hold
95,197
7.1% 6
2014
Q4
$11.5M Buy
+95,197
New +$11.5M 7.49% 5
2014
Q2
Sell
-95,197
Closed -$12.2M 17
2014
Q1
$12.2M Buy
+95,197
New +$12.2M 9.02% 3